Preclinical profiling of virosomally formulated B-cell epitope mimetics derived from the novel key malaria vaccine candidates CyRPA and RH5

Clinical testing of two components for a synthetic peptide-based virosomal malaria vaccine has yielded promising results, encouraging the search for additional components for inclusion in a final multivalent vaccine formulation. This CTI project should support design, optimisation and final...

01.09.2015 - 31.08.2017
Research project
Commission for Technology and Innovation (CTI)
Molecular Immunology
Marco Tamborrini
Survey on customer satisfaction and improvement potential of the Swiss TPH Administration

Um die Dienstleistungen der Administration konsequent auf die Bedürfnisse der Mitarbeitenden auszurichten, wurden zwischen 2015 und 2017 drei Querschnittbefragungen zur Zufriedenheit mit den administrativen Dienstleistungen durchgeführt. Die Kundenzufriedenheit mit den administrativen...

29.06.2015 - 08.01.2018
Organisational Development Project
MuLeVaClin - Clinical Studies on a Multivalent Vaccine for Human Visceral Leishmaniasis

Leishmaniasis was declared at the 60th WHO Assembly (2007) one of the world’s most neglected diseases. Leishmaniasis affects largely the poorest of the poor, mainly in developing countries as India, Bangladesh, Sudan, Ethiopia and Latin America. Existing treatments have severe drawbacks: side...

01.11.2013 - 30.09.2018
Clinical Trial
Molecular Immunology, Clinical Operations
Gerd Pluschke , Christian Burri , Marco Tamborrini